News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
eFFECTOR Therapeutics announces the initiation of an investigator-sponsored trial in collaboration with the Dana-Farber Cancer Institute
Photo taken from eFFECTOR Therapeutics/LinkedIn
May 22, 2024, 14:42

eFFECTOR Therapeutics announces the initiation of an investigator-sponsored trial in collaboration with the Dana-Farber Cancer Institute

eFFECTOR Therapeutics shared a post on LinkedIn:

“We are excited to announce the initiation of an investigator-sponsored trial evaluating our lead product candidate in patients with estrogen receptor-positive (ER+) endometrial cancer ovarian cancer, in collaboration with the Dana-Farber Cancer Institute. ”

Source: eFFECTOR Therapeutics/LinkedIn

cancer Dana-Farber Cancer Institute eFFECTOR Therapeutics estrogen receptor-positive endometrial cancer OncoDaily Oncology Ovarian Cancer
Special Coverage
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer
Blog
Dec 21, 2024, 11:12
Didier Verhoeven: Comparing survival in breast cancer in Belgian Breast Centres
Blog
Dec 21, 2024, 11:06
Every great journey has its finale - eCAN Joint Action
Drugs
Dec 21, 2024, 10:38
Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024